Mallinckrodt to spin off generic drugs business; specialty drugs to be based in New Jersey
December 06, 2018 at 14:29 PM EST
St. Louis-area pharmaceutical company, Mallinckrodt, announced that it plans to spin off its generic drug business in 2019.